This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

Michael Osterholm, PhD, MPH, a University of Minnesota infectious disease researcher, likened this binding interaction to a ...

Artificial intelligence (AI)-aided analysis of pathology slides showed potential as a predictive biomarker for non-small cell ...

Initiating cognitive processing therapy or prolonged exposure (CPT/PE) sessions for post-traumatic stress disorder (PTSD) was ...

Most Americans believe health insurance profits and coverage denials share responsibility for the killing of UnitedHealthcare ...

A study presented at the San Antonio Breast Cancer Symposium examined whether tumor mutational burden (TMB) was associated with outcomes in hormone receptor-positive, HER2-negative metastatic breast ...

But recent FDA-sponsored testing hasn't uncovered any safety issues. Since 2021, laboratory analysis of more than 150 ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

Alpelisib, we ran into a lot of toxicities, but they were all alpelisib toxicities. So a lower dose will be tested in the next cohort with elacestrant. And then capivasertib [Truqap] is in the early ...